Antiplatelet therapies such as aspirin and clopidogrel effectively reduce thrombo-occlusive events in stroke, though their benefit must be weighed against the risk of abnormal bleeding.
No takes yet. Share an insight, caveat, or question.
May support combined antiplatelet regimens in stroke prevention; leaves open bleeding risk assessment and optimal duration in prospective trials.
Laurence A. Harker (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: